Status:
RECRUITING
Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
Aarhus University Hospital
Conditions:
Vulva Cancer
Sentinel Lymph Node
Eligibility:
FEMALE
18+ years
Brief Summary
The aim of the study is to evaluate the feasibility of applying the SLN mapping technique in combination with FDG-PET/CT imaging in women with vulva cancer tumour size \>4 cm, multifocal tumors and lo...
Eligibility Criteria
Inclusion
- Patients with vulva cancer, tumor \> 4 cm, multifocal tumor, or local recurrences in vulva
Exclusion
- Previous external irradiation of the vulva or groins
- Former sentinel node or inguinal lymphadenectomy in the relevant groin
- Known allergy to ICG or iodine
- Patient is in active treatment for other cancer and/or disseminated disease
Key Trial Info
Start Date :
May 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06161428
Start Date
May 1 2023
End Date
July 1 2027
Last Update
December 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Copenhagen University Hospital
Copenhagen, Denmark, 2100